# Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery

> **NCT02726438** · PHASE1 · COMPLETED · sponsor: **Debiopharm International SA** · enrollment: 17 (actual)

## Conditions studied

- Bone Diseases, Infectious

## Interventions

- **DRUG:** Debio 1450

## Key facts

- **NCT ID:** NCT02726438
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02726438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02726438, "Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02726438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*